Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cetuximab in Treating Patients With Stage IV Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas
- Status
- WITHDRAWN
- Phase
- PHASE2
Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
- Status
- TERMINATED
- Phase
- PHASE3
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3